| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVNT | Common Stock | Options Exercise | $84.2 K | +2.4 K | +44.99% | $35.07 | 7.73 K | Jan 8, 2024 | Direct | |
| transaction | AVNT | Common Stock | Disposed to Issuer | -$87.1 K | -2.26 K | -29.21% | $38.55 | 5.48 K | Jan 8, 2024 | Direct | |
| holding | AVNT | Common Stock | 28.1 K | Jan 8, 2024 | Supplemental Plan | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVNT | Stock Appreciation Rights | Options Exercise | $0 | -2.4 K | -100% | $0.00 | 0 | Jan 8, 2024 | Common Stock | 2.4 K | $35.07 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The information in this report is based on a plan statement as of January 8, 2024. |
| F2 | SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $35.07 per share and no more than one-third of the grant can vest per year during the first three years. |